Bibliographic citations
Guevara, M., (2023). Prevalencia de la infección por SARS-CoV-2 en pacientes atendidos en el Centro de Salud Melvin Jones - Alto Trujillo - El Porvenir, abril 2020 - julio 2021 [Universidad Nacional de Trujillo]. https://hdl.handle.net/20.500.14414/20539
Guevara, M., Prevalencia de la infección por SARS-CoV-2 en pacientes atendidos en el Centro de Salud Melvin Jones - Alto Trujillo - El Porvenir, abril 2020 - julio 2021 []. PE: Universidad Nacional de Trujillo; 2023. https://hdl.handle.net/20.500.14414/20539
@misc{renati/1044205,
title = "Prevalencia de la infección por SARS-CoV-2 en pacientes atendidos en el Centro de Salud Melvin Jones - Alto Trujillo - El Porvenir, abril 2020 - julio 2021",
author = "Guevara Paredes, Mónica Patricia",
publisher = "Universidad Nacional de Trujillo",
year = "2023"
}
The infection by the SARS-CoV-2 virus causes the Covid-19 disease, this is considered a public health problem due to the pandemic that it caused in 2020 and 2021, in Peru the first case was reported on March 6, 2020 rapidly increasing the number of cases exponentially. The main objective of the study is to determine the prevalence of SARS-CoV-2 infection in patients treated at the Melvin Jones Health Center - Alto Trujillo - El Porvenir, April 2020 - July 2021. A descriptive, cross-sectional and retrospective study was carried out. , which included 1125 patients with SARS-CoV-2 infection between the months of April 2020 to July 2021 who met the criteria required for the investigation, the information was collected from the clinical epidemiological investigation sheets of each patient and from the integrated system for COVID-19 (SISCOVID) the data were presented in figures, where a prevalence of 31.3% was obtained, the most affected group corresponds to the female sex with 60% in patients between 30 and 39 years old with a 21.9% prevalence. Regarding the frequency of antibodies, the IBM SPSS version 22 program was used; It was obtained that the IgM and IgG type is presented in a higher percentage 74.91%, being the female sex the most affected with 71.2%, the age group with the highest prevalence was 30 -40 years with 92.3%.
This item is licensed under a Creative Commons License